Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea
Author:
Affiliation:
1. Health Insurance Review and Assessment Service, Seoul, Korea.
2. Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Publisher
Mary Ann Liebert Inc
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.liebertpub.com/doi/pdf/10.1089/thy.2014.0557
Reference39 articles.
1. Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
2. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: A nationwide, population-based study in Korea
3. The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
4. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
5. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risk of Lymphoma and Leukemia in Thyroid Cancer Patients: A Retrospective Cohort Study in Germany;Hormone and Metabolic Research;2024-06-13
2. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 3. Radioactive Iodine Therapy in Advanced Thyroid Cancer 2024;International Journal of Thyroidology;2024-05-30
3. Cancer Risk in Graves Disease with Radioactive131I Treatment: A Nationwide Cohort Study;Journal of Nuclear Medicine;2024-03-28
4. Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma;Cancer;2024-02-20
5. Reversible anion-dependent iodine uptake in nonporous pseudopolymorphic coordination polymers;CrystEngComm;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3